On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

GJC2

gap junction protein gamma 2

The GJC2 gene provides instructions for producing connexin-47, a protein vital for forming gap junctions that facilitate communication between cells in the central nervous system. The GJC2 gene encodes the connexin-47 protein, which is essential for the formation and maintenance of myelin, the protective sheath around nerve fibres.

Chromosome 1q42.13 Various HGNC:17494 Tier C
GJC2 1q42.13 p arm q arm 1

GJC2 is located on the long (q) arm of chromosome 1, at band 1q42.13. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 1 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The GJC2 gene is responsible for generating connexin-47, a protein belonging to the gap junction connexin family. These proteins are fundamental for creating gap junctions, which are channels that allow for the direct transfer of nutrients, ions, and small molecules between cells. Connexin-47 is predominantly found in the brain and spinal cord, specifically within oligodendrocytes, cells critical for myelin production around nerve cells.

What the gene does

The primary role of the GJC2 gene product, connexin-47, is to form gap junctions within the central nervous system. These junctions are crucial for facilitating intercellular communication, particularly between oligodendrocytes, or between oligodendrocytes and astrocytes. Oligodendrocytes are responsible for creating myelin, a fatty substance that insulates nerve fibres and enables the rapid transmission of nerve impulses. Effective communication facilitated by connexin-47 is therefore essential for both the development and ongoing maintenance of this vital myelin sheath.

Video: Genetics 101

Chromosome location

The GJC2 gene is located on chromosome 1 at position 1q42.13. This specific genomic location provides its address within the human genome.

Protein structure

The GJC2 gene encodes a protein composed of 439 amino acids. The protein includes two notable disordered regions: one spanning amino acids 108-178 and another from amino acids 364-439. These regions typically lack a fixed three-dimensional structure under physiological conditions.

Key variants

Variants within the GJC2 gene can impact the function of the connexin-47 protein, potentially leading to a range of neurological conditions. The severity and specific manifestations of these conditions can vary depending on the nature and location of the genetic change.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for GJC2.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
g.228149857A>G
single nucleotide variant
- Pathogenic/Likely pathogenic ★★☆☆ Spastic paraplegia
c.1134_1144del
Deletion
p.Ala379fs Pathogenic/Likely pathogenic ★★☆☆ Hereditary spastic paraplegia 44
c.1141_1151del
Deletion
p.Ser381fs Pathogenic ★★☆☆ Spastic paraplegia
c.17G>A
single nucleotide variant
p.Trp6Ter Pathogenic/Likely pathogenic ★★☆☆ Leukodystrophy, hypomyelinating, 2
c.-20+1G>C
single nucleotide variant
- Pathogenic ★★☆☆ Lymphatic malformation 3
c.23_24delinsAA
Indel
p.Phe8Ter Pathogenic ★★☆☆ Leukodystrophy, hypomyelinating, 2
c.392del
Deletion
p.Pro131fs Pathogenic/Likely pathogenic ★★☆☆ Spastic paraplegia
c.591dup
Duplication
p.His198fs Pathogenic/Likely pathogenic ★★☆☆ Spastic paraplegia
c.69_82dup
Duplication
p.Leu28fs Pathogenic/Likely pathogenic ★★☆☆ Spastic paraplegia
c.970_971dup
Duplication
p.Ala325fs Pathogenic/Likely pathogenic ★★☆☆ Spastic paraplegia

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Mutations in the GJC2 gene are associated with several inherited conditions, primarily affecting the nervous system. These include Pelizaeus-Merzbacher-like disease type 1, which affects the brain's white matter and typically causes movement abnormalities. GJC2 variants are also linked to spastic paraplegia type 44, characterised by muscle stiffness and impaired speech, and a form of hereditary lymphoedema causing limb swelling.

No disease links recorded for this gene in our reference set.

UK clinical status

The GJC2 gene is included in several NHS England Genomic Medicine Service approved panels. These include 'Ataxia and cerebellar anomalies - childhood onset', 'Dystonia, chorea or related movement disorder, childhood onset', 'Hereditary ataxia', and 'Inherited white matter disorders', all categorised as green for their clinical utility.

Frequently asked questions

What is the GJC2 gene?

The GJC2 gene provides instructions for making connexin-47, a protein that forms channels called gap junctions between cells. These junctions are critical for communication, especially in the brain and spinal cord where they support myelin formation.

What conditions are associated with GJC2 gene variants?

Variants in the GJC2 gene are associated with conditions such as Pelizaeus-Merzbacher-like disease type 1, spastic paraplegia type 44, and a type of hereditary lymphoedema. These conditions primarily affect the nervous system and motor function.

Where is the GJC2 gene active?

The GJC2 gene is primarily active in the central nervous system, specifically in oligodendrocytes. These cells are responsible for producing myelin, the protective sheath around nerve fibres that enables rapid nerve impulse transmission.

References

  1. Gotoh L, Inoue K, Helman G. GJC2 promoter mutations causing Pelizaeus-Merzbacher-like disease. Molecular genetics and metabolism. 2014. PMID: 24374284
  2. Orthmann-Murphy JL, Salsano E, Abrams CK. Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations. Brain : a journal of neurology. 2009. PMID: 19056803
  3. Orthmann-Murphy JL, Freidin M, Fischer E. Two distinct heterotypic channels mediate gap junction coupling between astrocyte and oligodendrocyte connexins. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2007. PMID: 18094232
  4. Adam MP, Bick S, Mirzaa GM. Pelizaeus-Merzbacher-Like Disease 1. 1993. PMID: 29276893
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 11 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .